CME Group Inc.
CME · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $2 | $2 | $2 | $2 |
| % Growth | -9.1% | 3% | 7.7% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 84.5% | 86.9% | 87.4% | 85.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | $1 | $1 | $1 | $1 |
| % Margin | 63.3% | 66.7% | 67.5% | 62.1% |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | $1 | $1 | $1 | $1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $1 | $1 | $1 | $1 |
| % Margin | 59.1% | 59.8% | 58.2% | 57.3% |
| EPS | 2.49 | 2.81 | 2.63 | 2.4 |
| % Growth | -11.4% | 6.8% | 9.6% | – |
| EPS Diluted | 2.49 | 2.81 | 2.62 | 2.4 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $1 | $1 | $1 | $1 |
| % Margin | 84.8% | 86.2% | 83.4% | 80% |